Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study-Reference-Cited by-同舟云学术

Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study

Published:2021-11-18 Issue:12 Volume:8 Page:2235-2251
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann. Clin. Transl. Neurol.

Author:

Paul Friedemann¹^ORCID,Calabresi Peter A.²^ORCID,Barkhof Frederik³⁴,Green Ari J.⁵,Kardon Randy⁶⁷,Sastre‐Garriga Jaume⁸,Schippling Sven⁹,Vermersch Patrick¹⁰,Saidha Shiv¹¹,Gerendas Bianca S.¹²,Schmidt‐Erfurth Ursula¹³,Agoropoulou Catherine¹⁴,Zhang Ying¹⁵,Seifer Gustavo¹⁴,Petzold Axel¹⁶¹⁷¹⁸^ORCID

Affiliation:

1. NeuroCure Clinical Research Center and Experimental and Clinical Research Center Max Delbrueck Center for Molecular Medicine and Charité ‐ Universitätsmedizin Berlin Berlin Germany

2. Department of Neurology Johns Hopkins Hospital Baltimore MarylandUSA

3. Department of Radiology & Nuclear Medicine Amsterdam UMC Vrije Universiteit Amsterdam Netherlands

4. Institutes of Neurology & Centre for Medical Image Computing University College London London UK

5. Department of Neurology Multiple Sclerosis Center University of California San Francisco San Francisco CalifoniaUSA

6. Iowa City VA Center for Prevention and Treatment of Visual Loss Department of Veterans Affairs Hospital Iowa City University of Iowa Hospital and Clinics Iowa City IowaUSA

7. Department of Ophthalmology and Visual Sciences University of Iowa Hospital and Clinics Iowa City IowaUSA

8. Department of Neurology/Neuroimmunology Multiple Sclerosis Centre of Catalonia (Cemcat) Hospital Universitari Vall d'Hebron Universitat Autònoma de Barcelona Barcelona Spain

9. Neuroimmunology and Multiple Sclerosis Research Section University Hospital Zurich Zurich Switzerland

10. Univ. Lille Inserm UMR1172 LilNCog FHU Precise Lille France

11. Department of Neurology Johns Hopkins University Baltimore MarylandUSA

12. Department of Ophthalmology Vienna Reading Center Medical University of Vienna Vienna Austria

13. Department of Ophthalmology Medical University of Vienna Vienna Austria

14. Novartis Pharma AG Basel Switzerland

15. Novartis Pharmaceuticals Corporation East Hanover New JerseyUSA

16. Moorfields Eye Hospital The National Hospital for Neurology and Neurosurgery London UK

17. Queen Square Institute of Neurology University College London London UK

18. MS Center Amsterdam Amsterdam UMC (Locatie VUmc) Amsterdam Netherlands

Funder

Novartis Pharma

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51473

Reference47 articles.

1. Multiple Sclerosis

2. Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting

3. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

4. Correlation between morphological and functional retinal impairment in multiple sclerosis patients;Parisi V;Invest Ophthalmol Vis Sci,1999

5. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A future of AI-driven personalized care for people with multiple sclerosis;Frontiers in Immunology;2024-08-19

2. Retinal optical coherence tomography measures in multiple sclerosis: a systematic review and meta‐analysis;Annals of Clinical and Translational Neurology;2024-07-28

3. Loss of Cells in the Retinal Ganglion Cell Layer as an Early Indication of Neurodegeneration in Multiple Sclerosis;Journal of Integrative Neuroscience;2024-07-09

4. Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study;Neurological Sciences;2024-06-29

5. Artificial Intelligence and Multiple Sclerosis;Current Neurology and Neuroscience Reports;2024-06-28